1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SAFB2 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA CAPN2 CTRPv2 pan-cancer AAC -0.18 5e-06
mRNA NCOA5 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA CLASRP CTRPv2 pan-cancer AAC 0.18 5e-06
mRNA LRRC59 CTRPv2 pan-cancer AAC -0.15 5e-06
mRNA METTL24 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA CDK13 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA CEP97 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA KLHL25 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA YLPM1 CTRPv2 pan-cancer AAC 0.16 5e-06
Download CSV